Article
Cell Therapy Manufacturing: Build or Buy?
Allogeneic cell therapy is poised to be paradigm-shifting treatment from a scale, cost, and reach perspective. In this white paper, we discuss the considerations for…
Tag: cell therapy, manufacturing decisions, build vs buy, CDMO
Allogeneic cell therapy is poised to be paradigm-shifting treatment from a scale, cost, and reach perspective. In this white paper, we discuss the considerations for…